Adam E. Mullick
Adam E. Mullick
Ionis Pharmaceuticals, Inc.
Verified email at ionisph.com - Homepage
Title
Cited by
Cited by
Year
CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation
FJ Sheedy, A Grebe, KJ Rayner, P Kalantari, B Ramkhelawon, ...
Nature immunology 14 (8), 812-820, 2013
6792013
Modulation of atherosclerosis in mice by Toll-like receptor 2
AE Mullick, PS Tobias, LK Curtiss
The Journal of clinical investigation 115 (11), 3149-3156, 2005
6012005
Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans
MJ Graham, RG Lee, TA Bell III, W Fu, AE Mullick, VJ Alexander, ...
Circulation research 112 (11), 1479-1490, 2013
3062013
Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events
AE Mullick, K Soldau, WB Kiosses, TA Bell III, PS Tobias, LK Curtiss
The Journal of experimental medicine 205 (2), 373-383, 2008
2432008
ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
PLSM Gordts, R Nock, NH Son, B Ramms, I Lew, JC Gonzales, ...
The Journal of clinical investigation 126 (8), 2855-2866, 2016
1522016
Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein (a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in …
E Merki, MJ Graham, AE Mullick, ER Miller, RM Crooke, RE Pitas, ...
Circulation 118 (7), 743-753, 2008
149*2008
Antisense oligonucleotide lowers plasma levels of apolipoprotein (a) and lipoprotein (a) in transgenic mice
E Merki, M Graham, A Taleb, G Leibundgut, X Yang, ER Miller, W Fu, ...
Journal of the American College of Cardiology 57 (15), 1611-1621, 2011
1182011
Direct visualization of lipid deposition and reverse lipid transport in a perfused artery: roles of VLDL and HDL
JC Rutledge, AE Mullick, G Gardner, IJ Goldberg
Circulation research 86 (7), 768-773, 2000
942000
Hyperhomocysteinemia evoked by folate depletion: effects on coronary and carotid arterial function
JD Symons, AE Mullick, JL Ensunsa, AA Ma, JC Rutledge
Arteriosclerosis, thrombosis, and vascular biology 22 (5), 772-780, 2002
902002
Toll-like receptors and atherosclerosis
AE Mullick, PS Tobias, LK Curtiss
Immunologic research 34 (3), 193-209, 2006
822006
Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease
CM Ferrario, AE Mullick
Pharmacological research 125, 57-71, 2017
782017
Endothelial cell CD36 optimizes tissue fatty acid uptake
NH Son, D Basu, D Samovski, TA Pietka, VS Peche, F Willecke, X Fang, ...
The Journal of clinical investigation 128 (10), 4329-4342, 2018
772018
Modulation of apolipoprotein CIII (ApoCIII) expression
A Mullick, RM Crooke, MJ Graham, KW Dobie, R Lee
US Patent 9,157,082, 2015
712015
levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein (a) transgenic mice
E Merki, MJ Graham, AE Mullick
Circulation 118 (7), 743-753, 2008
622008
Modified LDL–Mediated Increases in Endothelial Layer Permeability Are Attenuated With 17β-Estradiol
G Gardner, CL Banka, KA Roberts, AE Mullick, JC Rutledge
Arteriosclerosis, thrombosis, and vascular biology 19 (4), 854-861, 1999
571999
Angiotensinogen exerts effects independent of angiotensin II
H Lu, C Wu, DA Howatt, A Balakrishnan, JJ Moorleghen, X Chen, M Zhao, ...
Arteriosclerosis, thrombosis, and vascular biology 36 (2), 256-265, 2016
532016
Hypercholesterolemia induced by a PCSK9 gain-of-function mutation augments angiotensin II–induced abdominal aortic aneurysms in C57bl/6 mice—brief report
H Lu, DA Howatt, A Balakrishnan, MJ Graham, AE Mullick, A Daugherty
Arteriosclerosis, thrombosis, and vascular biology 36 (9), 1753-1757, 2016
522016
Reactive carbonyls from tobacco smoke increase arterial endothelial layer injury
AE Mullick, JM McDonald, G Melkonian, P Talbot, KE Pinkerton, ...
American Journal of Physiology-Heart and Circulatory Physiology 283 (2 …, 2002
522002
Mechanism of increased LDL (low-density lipoprotein) and decreased triglycerides with SGLT2 (sodium-glucose cotransporter 2) inhibition
D Basu, LA Huggins, D Scerbo, J Obunike, AE Mullick, PL Rothenberg, ...
Arteriosclerosis, thrombosis, and vascular biology 38 (9), 2207-2216, 2018
492018
Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle
TP Prakash, AE Mullick, RG Lee, J Yu, ST Yeh, A Low, AE Chappell, ...
Nucleic acids research 47 (12), 6029-6044, 2019
472019
The system can't perform the operation now. Try again later.
Articles 1–20